90 likes | 397 Views
In Vitro Diagnostics. Challenge and Change Ahead The Medtech Marketplace 31 January 2007 Shara Rosen, RT, MBA Senior Analyst Kalorama Information New York, New York. The IVD Market 2005-2010. 7% Annual Growth. High-Growth IVD Areas. Immunoassays. Nucleic Acid Assays.
E N D
In Vitro Diagnostics Challenge and Change Ahead The Medtech Marketplace 31 January 2007 Shara Rosen, RT, MBASenior AnalystKalorama InformationNew York, New York In Vitro Diagnostics: Chalenge and Change Ahead
The IVD Market 2005-2010 7% Annual Growth In Vitro Diagnostics: Chalenge and Change Ahead
High-Growth IVD Areas Immunoassays Nucleic Acid Assays In Vitro Diagnostics: Chalenge and Change Ahead
Healthcare Delivery Trends and IVDs • The role of IVDs in the post genomics era • Healthcare decentralization • The impact of disease management • The role of IVDs in patient management In Vitro Diagnostics: Chalenge and Change Ahead
Devicesand Diagnostics Make for Innovation • GE Healthcare Amersham, Abbott • Siemens Bayer Diagnostics, DPC • Proctor & Gamble Inverness • Schering Plough OraSure • Philips Medical Systems BG Medicine In Vitro Diagnostics: Chalenge and Change Ahead
Thank You Shara Rosen, RT, MBA Senior AnalystKalorama Informationa division of MarketResearch.com, Inc.38 East 29th Street, 6th FloorNew York, New York 10016srosen@kaloramainformation.comwww.KaloramaInformation.com In Vitro Diagnostics: Chalenge and Change Ahead